One-Year Follow-Up of Collaborative Depression Care for Low-Income, Predominantly Hispanic Patients With Cancer

Abstract

Collaborative care reduced depression symptoms and enhanced quality of life; however, results call for ongoing depression symptom monitoring and treatment for low-income cancer survivors.

Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study

“…27,28,29 Only two trials targeted emotional well-being, both demonstrating efficacy in Hispanic populations. [30][31][32] There remains a need to evaluate interventions outside the Hispanic population to reduce depression and improve QOL in immigrants with cancer.…”

Psychosocial Care in Cancer

“…Similarly, collaborative models of care for depression in oncology settings, including a large cancer center in the United Kingdom and a cancer center serving low-income, predominantly Hispanic cancer patients in the United States, have been shown to be effective. Collaborative care models in these settings included a depression care manager with supervision from a psychiatrist, who provided problem-solving therapy, antidepressant treatment, symptom monitoring, and relapse prevention, and were associated with significant reduction in depression symptoms and enhancement in quality of life compared with usual care [36,37]. Further research is needed to examine the impact and costeffectiveness of these types of collaborative psychosocial care models of joint care among physicians, nurses, and psycho-oncology teams.…”

Collaborative care for depression in medically ill patients

“…There is evidence for a significantly beneficial effect of collaborative care interventions on depression outcomes at the end of treatment with moderate effect sizes regarding depressive symptoms (SMD range: À0.46 to À0.74, n ¼ 5) and clinically meaningful treatment responses (OR range: 1.29-4.75, n ¼ 6). Long-term follow-up data on collaborative care treatment in cancer patients with depression suggests that these positive effects on depression outcomes can be sustained [30]. Evidence on depression remission (n ¼ 2) and depression-free days (n ¼ 1) is sparse and conclusions cannot be drawn.…”